Recommended Topic Related To:

Niferex-150 Forte

"The U.S. Food and Drug Administration today approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) to treat pregnant women experiencing nausea and vomiting.

Diclegis is a delayed-release tablet intended for women who have"...

Niferex-150 Forte

niferex® -150 forte Capsules
(ferrous asparto glycinate and polysaccharide iron) Complex

DRUG DESCRIPTION

Each powder-filled capsule for oral administration contains:

Iron
  Sumalate™* (elemental iron)............................. 50 mg
  Polysaccharide iron (elemental iron)...................100 mg
Succinic acid ....................................................... 50 mg
Vitamin C as Ester-C®†
  Ascorbic acid (as calcium ascorbate).................. 60 mg
  Threonic acid (as calcium threonate).................. 0.8 mg
Folic Acid, USP.................................................... 1 mg
Vitamin B12 (cyanocobalamin).............................. 25 mcg

* Sumalate™ (ferrous asparto glycinate) is a trademark of Albion International, Inc., Clearfield, Utah. U.S. patent pending.
† Ester-C® is a patented pharmaceutical grade material consisting of calcium ascorbate and calcium threonate. Ester-C® is a licensed trademark of Zila Nutraceuticals, Inc.

Inactive Ingredients: citric acid, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, gelatin, magnesium stearate, malic acid, modified food starch, pharmaceutical glaze, silicon dioxide, sodium benzoate, sodium citrate, sorbic acid, and titanium dioxide.

Last reviewed on RxList: 8/15/2008
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Parenting and Pregnancy

Get tips for baby and you.